Recent advances of multiple sclerosis research in Japan

Clinical Neurology

Volumn 49, Issue 9, 2009, Pages 549-559

  Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Anti aquaporin 4 antibody; Conventional form of multiple sclerosis; Epidemiology; Multiple sclerosis; Neuromyelitis optica; Opticospinal form of multiple sclerosis

Indexed keywords

ACEBUTOLOL; AQUAPORIN 4; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HUMORAL ANTIBODY; IMMUNOGLOBULIN G; INTERFERON BETA SERINE; INTERLEUKIN 8;

ASIAN; AUTOIMMUNITY; AUTOPSY; BLOOD BRAIN BARRIER; BRAIN DAMAGE; CEREBROSPINAL FLUID; CLINICAL RESEARCH; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; GEOGRAPHY; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INCIDENCE; JAPAN; JAPANESE; LATITUDE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NERVE; PHENOTYPE; PREVALENCE; REVIEW; SPINAL CORD; SPINAL CORD LESION; TH1 CELL; TH17 CELL; TREATMENT FAILURE; TREATMENT RESPONSE; UPREGULATION;

EID: 71949088471     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.49.549     Document Type: Review

References (44)

1. Noonan CW, Kathman SJ, White MC: Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002; 58: 136-138 (Pubitemid 34041953)
2. Barnett MH, Williams DB, Day S, et al: Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci 2003; 213: 1-6 (Pubitemid 36842857)
3. Wallin MT, Page WF, Kurtzke JF: Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 2004; 55: 65-77
4. Houzen H, Niino M, Kikuchi S, et al: The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 2003; 211: 49-53 (Pubitemid 36593267)
5. Itoh T, Aizawa H, Hashimoto K, et al: Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan. J Neurol Sci 2003; 214: 7-9 (Pubitemid 37100974)
6. Houzen H, Niino M, Kikuchi S, et al: The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 2003; 211: 49-53 (Pubitemid 36593267)
7. Kurtzke JF, Beebe GW, Norman JE Jr: Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution. Neurology 1979; 29: 1228-1235
8. Kuroiwa Y, Igata A, Itahara K, et al: Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology 1975; 25: 845-851
9. Shibasaki H, Kubo N, Nishitani H, et al: Nationwide survey of multiple sclerosis in Japan: reappraisal of clinical features. J Trop Geo Neurol 1992; 2: 73-82
10. Osoegawa M, Kira J, Fukazawa T, et al: Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 2009; 15: 159-173
11. Ishizu T, Kira J, Osoegawa M, et al: Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. J Neuol Sci 2009; 280: 22-28
12. Matsuoka T, Matsushita T, Osoegawa M, et al: Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 2008; 266: 115-125 (Pubitemid 351186531)
13. Matsuoka T, Matsushita T, Osoegawa M, et al: Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis. Mult Scler 2008; 14: 1181-1190
14. Kira J: Multiple sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-127
15. Kappos L, Freedman MS, Polman CH, et al: Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007; 370: 389-397 (Pubitemid 47189673)
16. Polman CH, Reingold SC, Edan G, et al: Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846
17. Chong H, Kira J, Tsai C, et al: Proposed modifications to the McDonald criteria for use in Asia. Mult Scler 2009; 15: 887-888
18. Lennon VA, Wingerchuk DM, Kryzer TJ, et al: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112 (Pubitemid 39626806)
19. Lennon VA, Kryzer TJ, Pittock SJ, et al: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477
20. Takahashi T, Fujihara K, Nakashima I, et al: Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007; 130: 1235-1243 (Pubitemid 47355956)
21. Misu T, Fujihara K, Kakita A, et al: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-1234 (Pubitemid 47355951)
22. Matsuoka T, Matsushita T, Kawano Y, et al: Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206-1223 (Pubitemid 47355945)
23. Matsushita T, Isobe N, Matsuoka T, et al: Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler 2009; 15: 834-847
24. Cabrera-Gómez J, Bonnan M, González-Quevedo A, et al: Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Mult Scler 2009; 15: 828-833
25. Cree BA, Reich DE, Khan O, et al: Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. Arch Neurol 2009; 66: 226-233
26. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al: The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114 (Pubitemid 29442132)
27. Nakashima I, Fujihara K, Miyazawa I, et al: Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075 (Pubitemid 44338534)
28. Pittock SJ, Lennon VA, Krecke K, et al: Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396
29. Matsushita T, Matsuoka T, Isobe N, et al: Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 2009; 73: 171-176
30. Pittock SJ, Lennon VA: Aquaporin-4 autoantibodies in a paraneoplastic context Arch Neurol 2008; 65: 623-629
31. Matsushita T, Isobe N, Matsuoka T, et al: Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. Mult Scler 2009 (in press)
32. Papadopoulos MC, Manley GT, Krishna S, et al: Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004; 18: 1291-1293 (Pubitemid 39561580)
33. Manley GT, Fujimura M, Ma T. et al: Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6: 159-163 (Pubitemid 30082359)
34. Watanabe A, Matsushita T, Doi H, et al: Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients. J Neurol Sci 2009; 281: 34-40
35. Nicchia GP, Mastrototaro M, Rossi A, et al: Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia 2009 (in press)
36. Ishizu T, Osoegawa M, Mei FJ, et al: Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005; 128: 988-1002 (Pubitemid 40675455)
37. Tanaka M, Matsushita T, Tateishi T, et al: Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 2008; 71: 974-981
38. Doi H, Matsushita T, Isobe N, et al: Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody. Mult Scler 2009; 15: 304-310
39. Kinoshita M, Nakatsuji Y, Kimura T, et al: Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009; 386:623-627
40. Wingerchuk DM, Lennon VA. Pittock SJ, et al: Revised diagnostic criteria for neuromyelitis optica Neurology 2006; 66: 1485-1489
41. Saida T, Tashiro K, Itoyama Y, et al: Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 2005; 64: 621-630 (Pubitemid 40261889)
42. Ochi H, Mei FJ, Osoegawa M, et al: Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b. J Neurol Sci 2004; 222: 65-73 (Pubitemid 38881508)
43. Warabi Y, Matsumoto Y, Hayashi H: Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 2007; 252: 57-61 (Pubitemid 44909191)